Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of edoxaban for resolution of left atrial thrombus in non-valvular atrial fibrillation
2015-004847-37Phase 2Completed
- Sponsor
- Fondazione G. d'Annunzio
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of edoxaban in Atrial fibrillation (AFib) and left atrial thrombosis, sponsored by Fondazione G. d'Annunzio. Primary endpoint: Complete left atrial thrombus resolution at 4 weeks. Started Jun 2021; status: completed.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)left atrial thrombosis
Beyond the preview
Go deeper on 2015-004847-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004847-37.